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ABSTRACT 
 
 
Corry, Kylie A. M.S., Purdue University, August 2015. Novel Insights into the 
Mechanistic Gene Regulation of STAT3 in Bone Cells. Major Professor: Jiliang 
Li. 
 
 
Many cells are involved in the orchestra that is bone homeostasis--particularly 
osteoclasts and osteoblasts, which mediate remodeling of bones. This creates a 
balance that must be kept in check, otherwise pathologies arise. The JAK-STAT 
signaling pathway is crucial to maintaining this balance. It has long been known 
that the transcription factor STAT3 has more profound effects on bone 
homeostasis than other members of the STAT family of proteins. Recently, a 
genetic condition called Job‘s Syndrome has been specifically linked to point 
mutations in the Stat3 gene. These patients present with severe bone 
abnormalities, including prominent foreheads, broad nasal bridges, and abnormal 
eye spacing. For this reason, our lab has extensively studied conditional 
knockouts of Stat3 in all three types of bones cells in mice and observed severe 
deficiencies in numerous parameters of normal bone phenotypes. STAT3 seems 
to play a principal role in the signaling that takes place upon mechanical loading 
of bone tissues and calling cells into action where they are needed. Furthermore, 
xi 
STAT3 has been found to be up-regulated in the early-response gene cluster 
following mechanical loading.  
Our current approach to studying STAT3‘s effects on bone includes both in vivo 
and in vitro comparisons of WT and KO STAT3 models. The conditional knock-
out of STAT3 in 8-week old mice revealed significant phenotypic variations as 
compared to the WT controls, while no significant differences were observed in 
cKO newborn pups. We also looked at immortalized WT and STAT3 KO cell lines. 
The STAT3 KO cells had diminished proliferation rates and decreased 
differentiation capabilities. Furthermore, STAT3 KO cells showed significantly 
reduced mRNA levels of both Wnt3a and Wnt5a when exposed to fluid shear 
stress. 
By employing available ChIP-seq data, we were able to elucidate the genome-
wide binding patterns of STAT3. From the peak distribution, we can begin to 
uncover novel downstream effectors of STAT3 signaling that are responsible for 
the observed phenotypes in our conditional knockout mouse model. A 
preliminary look at the ChIP-seq data reveals Wnt and Nrf2 signaling to be under 
the putative control of STAT3. In our further research, we endeavor to 
experimentally confirm the ChIP-seq data for STAT3 with RNA-seq experiments 
in the hopes of finding potential therapeutic targets for bone pathologies.
1 
CHAPTER 1. INTRODUCTION 
 
1.1   Skeletal System Biology 
 
The formation of the skeletal system is the distinguishing factor between 
vertebrates and invertebrates. The skeleton is much more than a mere 
framework for our bodies. The structure and conformation of the 206 bones that 
comprise the human skeleton establishes the foundation for our physical 
appearance; its differentiation and growth during embryonic development 
determines our size at birth, while its deterioration in later life marks the 
downward spiral away from the rapidity and dexterity of youth. Much focus is put 
on the mechanical aspects of bone, where it functions to transmit the forces 
generated by the muscles and creates a protective barrier to the vital organs. 
However, bone also provides storage for the body‘s supply of calcium and 
phosphorus. Bone has also been categorized as an endocrine organ for its role 
in balancing phosphate and energy metabolism through its secretion of two 
hormones, fibroblast growth factor 23 (FGF-23) and osteocalcin (1).  
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1.2  Skeletal Anatomy 
 
The skeleton can be divided into several groups: long bones, short bones, flat 
bones, irregular bones, and sesmoid bones. Long bone anatomy can further be 
divided into the ephiphysis, metaphysis, and diaphysis. The epiphyses are found 
at either end of the long bone, proximally and distally. They are the portion of the 
bone that articulates with the neighboring bones and are therefore covered with 
articular cartilage. The metaphysis is a wide, intermediate region between the 
epiphysis and the diaphysis that is considered part of the growth plate, or 
growing region. The diaphysis, or midshaft, of a long bone is the elongated, 
hollow portion between the metaphyses that surrounds a central marrow cavity 
that contains the bone marrow (2).  The skeleton is divided into the axial and 
appendicular portions. The axial skeleton is comprised of the bones that form the 
axis of the body and the bones that support and protect the organs of the head 
and trunk regions, including the bones of the skull, vertebral column, and rib cage. 
The appendicular skeleton is comprised of the bones of the pelvic and pectoral 
girdles as well as the bones of the upper and lower extremities. The girdles 
provide a point of attachment to the axial skeleton.  
 
1.3   Bone Tissue Structure 
 
Two types of bone tissue exist: compact and spongy bone. These types are 
distinguished not only by their porosity level, but also by where they are found 
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and their functions. Compact, or cortical, bone is relatively solid and can be found 
where external stresses come from a limited range of directions. Spongy, or 
cancellous, bone is less compact and is made of a network of bony rods, called 
trabeculae, which are separated by spaces. Spongy bone comprises the 
epiphyses of long bones and can withstand stresses from many directions. The 
trabeculae work by dissipating the external forces to the stronger, more massive 
cortical bone (1). 
 The outer surface of all bones is covered in a fibrous tissue called the 
periosteum. The fibers of tendons and ligaments intertwine with those of the 
periosteum to form a stable bridge between bones and muscles or one bone to 
another. The periosteum serves many purposes for bone, including isolating it 
from surrounding tissues, providing a route for nervous and circulatory supplies, 
and aiding in the growth and repair of bone. Lining the inside of bone is the 
endosteum. The functions of the endosteum are similar to those of the 
periosteum. Both types of bone tissue are composed of functional units called 
osteons. In compact bone, the osteons are arranged into Haversian systems. 
Concentric circles of lamellae are formed around central canals and run parallel 
to the long axis of the bone and contain spaces called lacunae where mature 
bone cells are found. Canaliculi are small channels that connect lacunae and link 
them to nearby blood vessels. In spongy bone, however, half osteons, or 
hemiosteons, instead of lamellae, form the trabecular pieces. 
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 Because of their proximity to the marrow cavity, the hemiosteons do not require 
central canals to supply their nutrients (1).  
Bone is a composite structure arranged in a hierarchical manner, whose 
extracellular matrix is composed of mineral, collagen, water, noncollagenous 
proteins, and lipids. The mineral portion of bone makes up between 50-70% of 
the adult bone and is composed of hyroxyapatatite crystals [Ca10(PO4)6(OH)2]. 
The majority of the collagen in bone is cross-linked type 1 collagen, and it 
accounts for 20-25% of its composition. About 10% of the collagens in bone are 
types III and V. The amount and maturity level of type 1 collagen found in bone 
has a profound effect on bone strength and energy required to fracture.  The 
mineral portion of bone provides stiffness while the collagen portion of bone 
provides resilience and ductility (1).  
 
1.4   Bone Cells 
 
Osteocytes are mature bone cells and are also the most abundant cells in bone. 
They work to maintain the normal bone structure by recycling the excess calcium 
in the bony matrix and by assisting in repairs. Osteocytes are also thought to be 
the main bone cells that sense mechanical loads and transduce the signals to 
induce a biomechanical response. This process is mediated through their 
intricate network of cellular extensions, providing connections to neighboring 
osteocytes via gap junctions (3). Osteoclasts, the bone resorbing cells, are very 
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large and contain 50 or more nuclei. They are derived from hematopoietic 
mononuclear precursor cells. Osteoclasts secrete acids and enzymes that 
function to dissolve bone matrix thereby releasing stored minerals. This process 
helps to regulate the levels of calcium and phosphate in the body. Osteoblasts, 
the bone forming cells, deposit calcium salts into the organic matrix of bone. 
When an osteoblast becomes completely encased in the matrix that it deposited, 
it begins differentiating into an osteocyte. All of the bone cells are able to 
communicate with one another either by direct cell contact or indirectly through 
signaling molecules (4).  
 
1.5   Osteoblasts and Bone Progenitors 
 
Osteoblast cells are derived from mesenchymal progenitors (mesenchymal stem 
cells). In addition to osteoblasts, these pluripotent progenitor cells are capable of 
aare involved in the differentiation of osteoblasts, including Hedgehogs, BMPs, 
TGF-β, PTH, and the Wnts. An important step in the differentiation of osteoblasts 
is the activation of the transcription factor Runx2. Runx2 is the ‗master switch‘ for 
osteoblast differentiation. This is demonstrated by that fact that mice deficient in 
Runx2 expression have no mature osteoblasts and fail to form a mineralized 
matrix (5). The differentiation of the osteoblasts is arrested during both 
endochondral and intramembranous bone formation. Runx2 goes on to regulate 
the expression of the zinc-finger-containing transcription factor Osterix (Osx). 
Mice that lack Runx2 expression also lack expression of Osx, however, Osx-null 
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mice still express Runx2, meaning Osx operates downstream of Runx2. Osx is 
also required for the complete differentiation of osteoblasts but does not seem to 
have an effect on the patterning of the skeleton during development as, 
evidenced by Osx null embryos being indistinguishable from their wild type 
counterparts (6). Osterix controls the expression of target genes, including 
osteocalcin, osteopontin, osteonectin, and type I collagen (4,7).  
Wnt signaling is also known to heavily influence the generation and survival of 
osteoblasts. Wnt signaling is especially important in regulating the balance 
between adipogenesis and osteoblastogenesis—it inhibits adipogenesis and 
stimulates osteoblastogenesis (8). Conditional knockout of β-catenin, the Wnt 
intercellular signaling molecule, led the common osteochondroprogenitor cells to 
exclusively differentiate into chondrocytes rather than osteoblasts during 
intramembranous and endochondral bone formation (9). Gain-of-function 
mutations in the co-receptor for Wnt signaling, LRP5, lead to a high bone mass in 
mice and humans (10). Wnts are also capable of pushing undifferentiated 
mesenchymal cells towards the osteoblastic phenotype.  
 
1.6  Osteoclast-Osteoblast Communication 
 
In order for bone homeostasis to maintain normal bone mass, the bone cells 
must communicate with each other. They accomplish this by utilizing cell-to-cell 
contacts, diffusible paracrine factors, and cell-to-matrix interactions. These 
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processes will ultimately trigger intercellular signaling that modulates bone 
resorption and formation. The RANKL-RANK-OPG signaling system is one way 
to control osteoclast formation and, in turn, bone resorption. Stromal cells, 
osteoblasts, and osteoclasts contain RANKL on their cell surface; however, 
RANKL can also function in a soluble form. RANKL can bind to two different 
receptors, RANK or osteoprotegrin/tumor necrosis factor receptor superfamily 
member 11B (OPG). Osteoclasts precursor cells express RANK as a 
transmembrane protein receptor while OPG is produced as a soluble, secreted 
molecule. OPG contains a similar N-terminal region that allows it to function as a 
decoy receptor for RANKL. When RANKL binds to RANK, it leads to the 
activation of specific transcription factors that, in turn, will push the differentiation 
of mononuclear precursor cells into multinucleated osteoclasts. RANKL serves 
not only to differentiate osteoclasts, but also to promote their survival. OPG 
protects bone from over-resorption by neutralizing the activity of RANKL. The 
ratio of RANKL to OPG serves as a determinant of the amount of bone resorption 
taking place (11,12). Mice deficient in RANK have profound osteopetrosis resulting 
from a lack of osteoclast differentiation and subsequently decreased bone 
resorption (13). Though osteoblast-mediated RANKL production was thought to be 
the main contributor to osteoclast activation, emerging evidence suggests that 
RANKL produced by osteocytes is just as, if not more, crucial to osteoclast 
activation (14). 
8 
Bidirectional signaling between osteoclasts and osteoblasts also contributes to 
bone homeostasis. This signaling is mediated by a subgroup of ephrin proteins 
and their receptors. The ephrin-B-EphB system plays an especially important role 
in bone homeostasis and has been extensively studied in the context of bone. 
The bidirectional nature of this type of signaling allows it to couple bone 
resorption to bone formation. Reverse signaling involves ephrin-B2, expressed 
on the surface of osteoclasts, binding to Eph-B4 on osteoblasts—inhibiting bone 
resorption by deactivating hematopoietic precursors. The forward signaling event, 
from Eph-B4 back to ephrin-B2 on osteoclasts, triggers bone formation by up-
regulating osteoblasts specific transcription factors (4,11,12).  
 
1.7  Bone Formation 
 
Mesenchymal stem cells, the precursors to bone cell, found in different regions of 
the developing embryo are descendants of different cell lineages, therefore, the 
location of each skeletal formation event will determine from which mesenchymal 
lineage the new bone is derived. Positional identity of the new bone is acquired 
early in development, even before the mesenchyme begins to condense. Bone 
always arises secondary to a preexisting supportive tissue. The formation of 
bone begins around the third month of fetal development and continues through 
late adolescence before it begins to decline. Bone can be formed through two 
distinctly different processes: endochondral or intramembranous ossification. 
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These types of bone formation differ in the local environment in which they are 
initiated and in what cells are producing the matrix. Endochondral ossification 
first begins with the deposition of a hyaline cartilage model by chondrocytes, 
which later becomes calcified by osteoprogenitor cells. Intramembranous 
ossification is not preceded by the formation of a cartilaginous template. 
Mesenchymal stem cells, rather, form condensations and begin differentiating 
into osteoprogenitor cells that will later become osteoblasts. The majority of 
bones form through endochondral ossification during development, with the flat 
bones of the skull, the mandible, and the clavicles being the exceptions.  
Although intramembranous ossification is often associated only with embryonic 
development, it is also essential to the natural process of healing bone (15). 
 
1.8  Bone Modeling and Remodeling 
 
The functioning of the osteoclasts and osteoblasts continues even after the 
epiphyseal plates have closed. Under normal physiological conditions, the 
activity of the osteoclasts is balanced with that of the osteoblasts during the 
turnover of bone in a process called bone remodeling. The turnover rate for bone 
is fairly high, though not every part of bone is affected. This high turnover rate 
gives bone the ability to respond and adapt to new stresses, mainly in the form of 
external forces, and is a unique feature among the other connective tissues. 
Bone remodeling is controlled through local, endocrine, and neuronal factors. 
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During growth, the rate of bone remodeling is high, with formation exceeding 
resorption resulting in a net increase in bone mass. This begins to decline later in 
life when resorption begins to outpace formation.   
Bone modeling can be thought of as the uncoupling of bone remodeling, either 
the formation of bone through osteoblasts or the resorption of bone through 
osteoclasts, on any given surface, signaled by local tissue strain. Bone modeling 
is necessary because longitudinal growth alone would not produce the correct 
geometry. The process of bone modeling allows bone to increase its mass and 
either maintain or alter its shape. Although the resorption and formation are 
uncoupled in bone modeling, they must still be coordinated throughout the body 
to shape the bone. Bone modeling occurs in two phases: an activation phase 
where precursor cells are recruited to a particular site, and then either formation 
or resorption of bone. This process will continue until enough bone mass has 
been added or removed in order to equilibrate the amount of local strains. Bone 
modeling is less common in the adult under normal physiologic conditions, but 
some modeling does take place (15). 
 
1.9  Bone Biomechanics 
 
During every day normal activities, bone is called upon to handle dynamic 
mechanical stimuli. Bone‘s ability to deal with these types of stimuli are 
dependent upon the type of load applied and with what force, as well as the 
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underlying structural properties of the bone receiving the load. Failure occurs if 
the load exceeds the structural strength of the bone. It is these mechanical 
demands that heavily influence the biologic response that bone initiates. There 
are many different types of stresses that bone can incur, including tension, 
compression, shear, torsion, and bending. When a force is applied to bone in one 
of these manners, deformation of the bone will take place. The amount of 
deformation can be graphed as a function as the force applied, producing a 
force-displacement curve. Extrinsic properties of the bone structure as a whole 
can be determined from this curve. The initial portion of the curve is linear and is 
referred to as the elastic region. Within this region of the curve, no energy is lost 
and no permanent deformation takes place. The slope of the curve in the elastic 
region is equivalent to the structural stiffness of the bone. Past the elastic region, 
a certain amount of force will result in irreversible damage. This is called the yield 
point, where the curve begins to behave in a non-linear manner. The amount that 
the bone continues to deform after the yield point is a measure of ductility. Once 
the applied force reaches the ultimate load, the bone will fail. The amount of work, 
or energy, required to fail the bone is referred to as toughness. Other parameters 
that can be calculated from the force-displacement curve include: structural 
strength, stiffness, deformation, and energy dissipation (16,17).   
The force-displacement curve is based on the bone structure as a whole and is 
dependent upon the mass, geometry, and mineral properties of the bone. To 
study only the material properties of the bone, it is necessary to normalize out the 
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effects of geometry. To do this, one must look at strain and stress. Stress is 
measured in units of force per unit area and strain measures the fractional 
change in dimension of the loaded body. The force-displacement curve can be 
converted to a stress-strain curve using the appropriate formulas to change force 
to stress and displacement to strain. This stress-strain curve represents the 
material properties of the bone without regard to the bone‘s geometry or mass, 
and properties that are analogous to the ones on the force-displacement curve 
can be derived. These strength terms now apply to the material in terms of 
stresses. The maximum stress, or ultimate stress, represents the toughness of 
the material and is equivalent to the total amount of energy absorbed before 
failure is achieved. Young‘s modulus, another material property, is defined as the 
ratio of stress to strain. This can be rewritten as Hooke‘s Law, or the equation of 
the linear portion of the stress-strain curve. A larger modulus means that a larger 
amount of stress is needed to achieve a given level of strain. 
 
1.10  STAT Family 
 
The STAT family is a highly conserved class of transcription factors ranging in 
size between 750 and 800 amino acid residues in length, further characterized by 
the presence of the Src homology 2 (SH2) domain and a carboxyl-terminal 
tyrosine phosphorylation site. The SH2 domain is required for STAT proteins to 
bind to receptor motifs and for dimerization (18). Currently, there are seven known 
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mammalian STAT family members that have been discovered and can be 
mapped to three different mouse chromosomes. STAT1 and STAT4 are found on 
chromosome 1, STAT2 and STAT6 on chromosome 10, and STAT3, STAT5a, 
and STAT5b are found on chromosome 11. Most of the STAT proteins 
participate in host defense and are only expressed in a few cell types, while 
STAT3 and STAT5 are expressed and function in most cell types(19). No other 
STAT genes have been discovered in the genomes of unicellular systems, 
suggesting that the STAT proteins evolved along with the development of 
multicellular organisms (20).  
Experiments designed to understand interferon-induced transcriptional activity 
helped reveal a novel pathway of signal transduction called the JAK-STAT 
pathway. The JAK family of kinases, including Jak1, Jak2, Jak3, and Tyk2, vary 
in size from 120-135 kDa (21). Jaks serve as soluble intracellular tyrosine kinases 
with their N-terminal half interacting with the associated receptor (20,21). Cytokines 
play a crucial role in JAK-STAT signaling. The family of cytokines containing the 
common receptor subunit glycoprotein 130 (gp130) includes interleukin 6 (IL-6), 
IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic 
factor (CNTF), and cardiotrophin 1 (CT-1) (20)(Figure 1). These cytokines are of 
similar molecular mass, about 20 kDa. The gp130 subunit allows for signal 
transduction that results in similar physiological effects amongst the different 
cytokines. 
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This subfamily is referred to as ‗IL-6-type cytokines‘ and they all signal through 
the activation of gp130-associated Janus kinases and the STAT family of 
transcription factors.  
 
1.11  STAT Signaling 
 
STAT proteins are found in the cytoplasm in their inactive form. Once one of the 
requisite cytokines binds to its surface receptor, it recruits gp130 to the receptor 
complex. This recruitment causes the tyrosine residues to become 
phosphorylated in the cytoplasmic tail of the receptor leading to dimerization, 
while simultaneously activating the Jak kinases. The phosphorylated tyrosine 
residues of the gp130 receptor then serve as a docking site for STAT proteins. 
The SH2 domains of the STAT proteins recognize these phosphorylated tyrosine 
residues. The Jak kinases are then able to phosphorylate the recruited STAT 
proteins at their own tyrosine residues near the C-terminus. Consistent with the 
other STAT proteins, STAT3 is phosphorylated at a particular tyrosine, Y705, and 
a particular serine, S727 (22). This allows the phosphorylated STAT proteins to 
detach from the receptor domain, dimerize, and then translocate to the nucleus 
(Figure 2). Dimerization of STAT proteins is required for DNA binding (18). Once in 
the nucleus, the hetero- or homodimer of STAT proteins bind to enhancer 
elements--activating transcription through its interaction with specific DNA 
sequences of the target genes (20,21,23).  
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Common results of IL-6-type cytokine activation include cell proliferation, 
differentiation, and gene activation (20). In certain cell cultures, STAT3 has also 
been shown to be activated by growth factors, oncogenes, and interferons. The 
genes that seem to be regulated by STAT3 activation include antiapoptotic and 
proliferation genes like Bcl-xL, Bcl-2, Fas, Cyclin D1, Survivin, and c-Myc (24). The 
activation of STAT proteins is transient, and deactivation can occur via many 
mechanisms, including dephosphorylation in the nucleus and subsequent protein 
degradation carried out by the ubuiquitin-proteosome pathway (25). Some cancers 
exhibit constitutively active STAT3 expression that enhances the growth of 
tumors (26).  
 
1.12  STAT3 Structure 
 
The protein structure of STAT3 is similar to that of the other STAT family 
members, containing multiple domains, each with a distinct function, as shown in 
Figure 3. STAT3 contains a highly conserved amino-terminus that is involved in 
the tetramerization of the protein structure, a DNA-binding domain specific to 
palindromic regions, an SH2 domain involved in receptor localization and protein 
dimerization, and a carboxy-terminal domain responsible for STAT activation (22). 
Through a systematic deletion of domains and site-directed mutagenesis, it was 
possible to determine how STAT3 is translocated to the nucleus. A coiled-coil 
domain of STAT3 was found to be responsible for its nuclear translocation. This 
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unique sequence, along with a conserved portion of the DNA binding domain, 
allows for the nuclear translocation of STAT3 (27). Differences in the activation of 
different STAT proteins arise from the specificity in the SH2 domain of each 
STAT protein (28).   
 
1.13  STAT3 Discovery 
 
Among the seven members of the STAT family, STAT3, STAT5a, and STAT5b 
have been shown to have direct involvement in skeletal development with STAT3 
having the most profound effect on bone. STAT3 was first discovered binding to 
DNA in IL-6-stimulated hepatocytes and identified as acute phase response 
factor (APRF) because it was specifically found binding with an enhancer 
element in the promoter region of acute-phase genes. APRF was then purified 
and cloned from the mouse liver extracts.  APRF transcripts were subsequently 
found in several different tissue types, including heart, brain, placenta, and lung 
(29).  
Universal knockout of STAT3 expression is lethal past embryonic day seven, 
prior to gastrulation, showing that STAT3 is crucial during early embryonic 
development, especially for mesoderm formation (30). Up until embryonic day six, 
the embryos appear normal, suggesting that STAT3 is not required for the 
formation of the egg cylinder, but nutritional insufficiencies as a result of STAT3 
knock-out cause the degeneration of the embryo. STAT3 is the only member of 
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the STAT family whose deficiency leads to the death of the animal. The role that 
STAT3 plays in tissues must be studied using Cre-loxP recombination systems to 
conditionally knockout the gene for STAT3 in specific tissues of study.  
 
1.14  Maintenance of Pluripotency in Embryonic Stem Cells 
 
STAT3 is not only required for the maintenance of embryonic stem cells in a 
pluripotent state, it is also sufficient (31). Self-renewal of the embryonic stem cells 
is propagated through LIF and other members of the IL-6 family of cytokines. 
Without STAT3 expression in ES cells, the cells will begin differentiating. These 
findings are intriguing when paired with the knowledge that STAT3 is known to 
induce the differentiation of somatic cell types (32).  
 
1.15  Hyper-IgE Syndrome 
 
In 1966, Davis and his colleagues described a case study of two girls with 
recurring episodes of pneumonia, eczema-like rashes, and recurrent skin boils 
lacking warmth or tenderness. They termed this condition ―Job syndrome‖ (33).  
Later, in 1972, Buckley et al. described a similar condition reminiscent of the 
repeated staphylococcal abscesses seen in Davis‘ patients in two adolescent 
boys, with the inclusion of exceptionally high serum concentrations of 
immunoglobulin E (IgE) and eosinophilia. The concentrations of the other 
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immunoglobulins were normal. The patients also had marked growth retardation, 
joint abscesses, and chronic dermatitis (34). High levels of IgE were later found in 
Davis‘ patients and these syndromes were merged into one: Hyper-IgE 
Syndrome (HIES).  
Recent genetic studies have linked a homozygous mutation in the tyrosine 
kinase2 (TYK2) and a heterozygous mutation in the STAT3 gene to be causal in 
HIES (24,35,36). Holland et al. were the first to discover STAT3‘s link to HIES. They 
observed that mononuclear cells from HIES patients stimulated with IL-6 had 
lower levels of monocyte chemoattractant protein 1. This result suggested a 
defect in the IL-6-mediated signaling pathway and its downstream effectors, 
including STAT3. The mutations were found in either the DNA binding region or 
the SH2 domains of STAT3 (24).  
In addition to the immunological manifestations of this syndrome, HIES presents 
with a range of pleiotropic effects, including craniofacial, dental, musculoskeletal, 
neurological, and vascular abnormalities (37)(Figure 4). Patients with HIES have 
notable skeletal abnormalities, including prominent foreheads and chins, deep-
set eyes, broad noses, and high arched palates. Most patients also present with 
recurrent fractures caused by seemingly minor traumas, occurring in the long 
bones, ribs, and pelvic bones (38). These fractures can be attributed to an 
enhancement of osteoclastogenesis and osteopenia (39). A hallmark of treatment 
for HIES is to prevent skin and pulmonary infections with prophylactic 
antibacterial and antifungal treatment. Bone marrow transplants have been 
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attempted for HIES patients with variable results (37). Cytokine replacement has 
been proposed as a novel therapy, however it is unclear whether the multiple 
functions attributed to STAT3 can be compensated for, and even then it appears 
that the total reversal of HIES is unattainable.  
 
1.16  Regulators of STAT3 
 
As noted earlier, STAT3 activation is a tightly controlled and transient process. 
There exist many negative regulatory mechanisms that control the activation of 
STAT3 under normal physiological conditions. These occur at different levels of 
the signal transduction pathway. There exist two strategies for inhibiting STAT3: 
indirectly by deactivating the upstream molecules in the JAK-STAT pathway or 
through direct targeting of the STAT3 protein itself. Activated STAT3 is able to 
bind to the promotor regions of suppressor of cytokine signaling (SOCS) genes 
(40). SOCS then go on to interact with the kinase domains of different JAK 
proteins associated with the membrane-bound receptors leading to the reduction 
of STAT3 activation. Another molecule, Src homology domain-containing tyrosine 
phosphatases 2 (SHP-2), is responsible for inactivating JAKs, STAT3, and their 
associated receptors through SHP-2‘s interaction with the intracellular domain of 
the cytokine receptors (41). Pharmaceutical companies have taken an interest in 
developing small-molecule inhibitors of STAT3 for the treatment of STAT3-
associated pathologies, especially cancers (42-44).  
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1.17  STAT3 in Bone 
 
STAT3, over the other STAT proteins, appears to have the most profound effect 
on bone homeostasis. Osteoblast cell culture studies have shown that 
osteoblasts respond to IL-6-type cytokines and signal through the JAK-STAT 
pathway (45). Further strengthening this result, it was found that all osteoblastic 
cells have receptors on their surfaces that are capable of responding to all 
members of the gp130 cytokine sub-family (46). Using a dominant-negative form 
of STAT3, it was determined that the activation of STAT3 is required for gp130-
dependent osteoclastogenesis through its targeting of RANKL expression in 
osteoblasts (47). The formation of osteoclasts, however, is not fully dependent 
upon gp130 signaling as evidenced by the presence of osteoclasts in gp130-
deficient mice (48). In addition to stimulating the differentiation and proliferation of 
osteoclasts, STAT3 is able to push osteoprogenitors towards a committed 
osteoblastic phenotype while indirectly regulating the differentiation of 
osteoclasts (45). Through conditional targeting of STAT3 in osteoblasts in vivo, 
mice lacking STAT3 expression in osteoblasts demonstrated an osteoporotic 
phenotype resulting from the lack of osteoblast activity. This implicates STAT3 as 
having a profound effect on normal osteoblast functioning (49). Recent studies 
have suggested that gp130 signaling affects bone formation and maintenance 
primarily via osteocytes, whose job it is to regulate the differentiation of 
osteoblasts and produce bone matrix (50).  
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The JAK-STAT signaling pathway has also been implicated in 
mechanotransduction in bone. When stimulated with fluid shear stress, 
osteoblastic cells significantly up-regulate the expression of STAT3 30-90 
minutes post-loading (51). In vivo ulnar loading studies have replicated these 
results—demonstrating that STAT3 plays a role in bone‘s responsiveness to 
mechanical loading.  
 
1.18  Bioinformatic Profiling 
 
Changes in the level of gene expression caused by abnormal level, inappropriate 
structure, or a non-functioning transcriptional regulator, like STAT3, have been 
directly linked to a number of human diseases (52). Chromatin 
immunoprecipitation (ChIP) followed by next generation sequencing (ChIP-seq) 
selectively enriches for DNA sequences that are bound by a particular protein in 
vivo. First described by Solomon and colleagues in 1988 (53), ChIP-seq is 
emerging as a widely used approach to map the genomic loci of transcription 
factor binding, providing increased annotation to the genome of different species. 
The process of ChIP-seq begins with cross-linking of DNA to DNA-binding 
proteins in vivo through the treatment with formaldehyde. Next, the chromatin is 
sheared into smaller pieces ranging in size from 200-600 base pairs.  
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An antibody specific to the protein of interest (STAT3) is used to 
immunoprecipitate out the DNA-protein complex so that the bound fragments can 
be sequenced. Most sequences from ChIP experiments go on to be sequenced 
with Illumina Genome Analyzer.  
ChIP-seq offers advantages over its contemporaries, like a higher resolution, 
fewer artifacts, and greater coverage. Prior methods, like ChIP-chip, were 
severely limited by the amount of arrays that could be sequenced. These 
improvements allow for more precise mapping of the protein-bound sites within a 
genome (54). Discovering the genome-wide binding patterns of particular 
transcription factors can be immensely useful when a systems-level view of 
cellular processes being driven by that transcription factor are desired, especially 
if the absence of that transcription factor, as is the case for STAT3, causes major 
disruptions to homeostasis.  
New techniques, like ChIP-seq, allow for the generation of whole-genome 
binding patterns of transcription factors and other molecules that interact directly 
with DNA. The library of genes generated by ChIP-seq is first aligned to a 
reference genome, usually mouse or human. Once the enriched sequences have 
been aligned, the location of the nearest gene loci can be determined and 
quantified; this will give insight into the transcription factor‘s mechanism for 
regulating certain genes. The main disadvantage of ChIP-seq experiments is the 
current cost and availability. The associated costs with ChIP-seq include those 
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for machine depreciation and reagent costs (54). The ChIP portion of the 
experiment requires about 107 cells, which will yield about 10-100 ng of DNA.  
Kang and colleagues performed a meta-analysis of STAT protein ChIP-seq 
experiments in order to elucidate the genome binding behaviors of STAT proteins. 
They found that the ability of any given STAT protein to bind DNA is primarily 
determined by the particular cell type being studied rather than the STAT protein 
being studied. For example, STAT3 and STAT5 have more shared binding sites 
in T cells than STAT5 in T cells has in common with binding sites in non-T cells 
(55). STAT proteins recognize and bind very similar, and in some cases identical, 
DNA sequence motifs, yet they are still able to elicit pleiotropic effects in vitro. 
Recently, genome-wide analysis of STAT3 binding sites was performed to better 
understand its role in the anti-inflammatory response in macrophages. IL-10, an 
anti-inflammatory cytokine, signals through the JAK-STAT3 pathway to stimulate 
the transcription of genes that will in turn suppress the pro-inflammatory 
cytokines. The further examination of these putative downstream targets of 
STAT3 will help to reveal potential anti-inflammatory treatments once the whole 
signaling network has been characterized (56).  
In order to better understand what actions the downstream effectors of STAT3 
signaling participate in to generate the bone phenotypes, we have mined data 
from the Mouse Encyclopedia of DNA Elements (ENCODE) Consortium for 
transcription factors (57). The ENCODE database project was developed with the 
intentions of providing researchers with a novel understanding of the human 
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genome in the context of its biological functionality and indeed had fulfilled this 
goal by generating a catalogue of potential functional elements in the genome of 
multiple species (57,58). Elucidating the transcriptional regulatory elements that are 
responsible for the expression of each transcript poses a significant challenge, 
especially when faced with the complexity of cellular processes that a few 
transcripts can control. These types of whole genome analyses are mainly 
exploratory in nature but are still helpful in understanding biological phenomena 
in the context of gene regulation. The evaluation of the meaning of the output of 
gene lists from ChIP-seq experiments requires the support of bioinformatics 
software packages, such as Ingenuity Pathway Analysis (IPA) and DAVID (the 
database for annotation, visualization, and integrated discovery). DAVID is 
especially useful because of its ability to handle any type or format of gene lists, 
regardless of which software package generated them.  
 
1.19  Research Goals 
 
Bone cells serve not only a biomechanical support function; they also take part in 
a homeostatic role by responding to local cytokines and circulating hormones. 
Osteoclasts and osteoblasts work in sequence to accomplish bone remodeling 
and it is this series of events that must be finely orchestrated, otherwise 
pathologies arise. It is our goal to target this imbalance in bone remodeling to 
correct skeletal pathologies, but first we must elucidate the basic molecular 
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interactions in bone formation and depletion. The JAK-STAT pathway is known to 
play a crucial role in the growth and differentiation of many cell types, including 
bone cells. STAT3, specifically, has a more profound effect on bone than the 
other STAT family of proteins. Through conditional knock-out studies in mice 
models, our lab has shown that STAT3 is particularly important in 
mechanotransduction. Recently, our lab has established an immortalized STAT3 
KO cell line derived from bone marrow stromal cells using CRISPR/Cas9. This 
cell line enables us to examine STAT3‘s role in differentiation and proliferation of 
bone progenitor cells in vitro. We therefore hypothesize that STAT3 also affects 
osteoblast differentiation and subsequently early skeletal development. In order 
to test this hypothesis, this study explores three specific aims: 1. to determine the 
role of STAT3 in skeletal development using an early-osteoblast-specific 
conditional STAT3 cKO mouse model with newborn and 8-week old mice, 2. to 
study STAT3‘s role in osteoblast differentiation and proliferation in vitro, and 3. to 
characterize the whole-genome binding patterns of STAT3 in order to find novel 
downstream targets of STAT3 signaling that could explain the skeletal 
phenotypes observed in our STAT3 cKO mice. 
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CHAPTER 2. MATERIALS AND METHODS 
 
2.1  Newborn cKO Mice 
 
To further understand the pre-osteoblast-specific STAT3 knockout phenotype, 
whole skeletons of newborn mouse pups were stained to visualize the amount of 
mineralized tissue compared to the amount of cartilage tissue present. 
Experimental mouse pups were bred using the same schematic for the 8-week 
old mice described below. The mice were collected from their cages between 0 
and 36 hours post-partum and were euthanized using isopropanol inhalation. The 
pups were visually assessed for gender via the presence or absence of scrotal 
pigmentation (59)(Figure 5). Because skin can block the penetration of the stains, 
the mice were skinned and eviscerated. The right limbs were removed to aid in 
imaging of the skeleton, and a piece of calcified tissue from the forelimb was 
extracted and processed for PCR, as described for the tail snips below. All the 
proceeding steps were performed on the shaker at RT. The pups were fixed in 95% 
ethanol overnight or up to two days. Next, lipids were removed by immersing 
them in acetone overnight before beginning the staining process. The pups were 
then immersed in a staining solution comprised of one volume 0.3% alcian blue 
8GX (dissolved in 70% ethanol), one volume 0.1% alizarin red 
27 
(dissolved in distilled water), one volume glacial acetic acid, and 17 volumes 70% 
ethanol. The pups were left to stain for 2-3 days or until the dye fully penetrated 
into the calcified tissue. After washing with 95% ethanol for one hour, the 
muscles were rendered clear using 1% KOH, which was changed every day until 
the muscles were completely clear. Lastly, the pups were passed through a 
series of glycerol/KOH washes and then stored in 80% glycerol. For long-term 
storage, KOH would leach out the dyes from the skeletons. Alizarin red staining 
stains hydroxyapatite crystals in bones while alcian blue stains 
glycosaminoglycans in cartilage tissues (60-62). All pups were imaged using a 
Stereologer system (Stereology Resource Center,Chester, MD) on a Nikon 
SMZ1500 microscope. 
PCR amplification and identification of the Osx-cre and STAT3 genes was 
performed as described below. Sex genotyping of the newborn pups was 
performed to confirm the gender of the newborn pups. Primers were designed 
based on the highly homologus SMC genes that are found on the X (X 
chromosomal SmcX) and Y (Y chromosomal SmcY) chromosomes. Primer 
sequences were as follows: SMCX-1 5‘- CCGCTGCCAAATTCTTTGG -3‘ and 
SMC4-1 5‘- TGAAGCTTTTGGCTTTGAG -3‘. The PCR product for female mice 
was a single band 350 bp in length while the males produced two bands, 300 bp 
and 350 bp in length (Figure 6). The Y-linked copies of the SMC genes have 
evolved 1.8 times faster than their X homologs accounting for an intron difference 
between the two (63).  
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The thermal cycles were ran as follows: 94°C for 3 minutes, 35 cycles of 94°C for 
30 sec., 54°C for 30 sec., 72°C for 30 sec., followed by one cycle of 72°C for 7 
minutes.  
 
2.2  8-week Old Conditional STAT3 Knockout Mice 
 
2.2.1  Experimental Animals 
 
All mice studies were reviewed and approved by the Indiana University Animal 
Care and Use Committee (IUACUC). Osteoblast-specific STAT3 knockout mice 
were generated using the cre-loxP recombinase system. Mice with floxed Stat3 
(STAT3flox/flox) were bred with mice expressing Cre recombinase driven by the 
promoter for Osterix--only expressed in early osteoblast cells. The STAT3 floxed 
mice were obtained from Dr. Xin-Yuan Fu in the Department of Microbiology and 
Immunology, Indiana University School of Medicine and the Osx-cre mice were 
purchased from Jackson Laboratory (Bar Harbor, ME). The loxP sequences of 
the STAT3 floxed mice flanked exons 18-20 of the Stat3 gene. These exons are 
responsible for encoding the SH2 domain of the STAT3 protein which is required 
for STAT3 activation (64). 
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2.2.2  Breeding Scheme 
 
The pre-osteoblast-specific STAT3 knockout (cKO) mice were generated through 
a two-step process. First, the homozygous Osx-cre transgenic mice were bred 
with homozygous STAT3flox/flox  mice to create F1 offspring carrying both 
heterozygous Osx-cre and heterozygous (STAT3flox/+) genes in the mice genome. 
The F1 offspring (Osx-cre; STAT3flox/flox) were then bred with each other to 
produce the F2 generation. Only two genotypes of the F2 generation were used: 
Osx-cre; STAT3flox/flox (cKO mice) and Osx-cre; STAT3+/+ (WT mice). It has been 
reported that Cre expression itself produces a phenotype and recent studies 
have suggested that Osx-cre expression might produce a phenotype(65). For this 
reason, we only used Cre (+) WT controls for this study. (Figure 7)    
 
2.2.3  Genotyping Mice 
 
The genotype of the experimental mice was confirmed using polymerase chain 
reaction (PCR) amplification of tail DNA. Approximately 2 mm was removed from 
the proximal tip of the tail and stored in a 1.5 mL microcentrifuge tube. Scissors 
were sterilized in between each mouse using 70% ethanol. The tails were 
immersed in a lysis buffer solution with 50 mM Tris, 50 mF KCL, 2.5 mM EDTA, 
0.4% NP-40, and 0.45% Tween-40. 0.4 mg/mL of proteinase K was added to the 
lysis buffer immediately before use. 100 µL of the lysis buffer: proteinase K 
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solution was alliquoted into each 1.5 mL microcentrifuge tube containing the tail 
snip and allowed to incubate in a 56°C water bath overnight. The next day the 
tubes were were transferred into a 95°C dry bath for 10 minutes to deactivate the 
proteinase K. The DNA tubes were then diluted with 100 µL autoclaved miliQ 
water. 1 µL of this DNA solution was then added to a PCR tube containing 12.5 
µL REDTaq ReadyMix (Sigma-Aldrich, St. Louis, MO, USA), 5.5 µL sterile PCR 
water, 0.5 µL (0.5 µM) forward primer, and 0.5 µL (0.5 µL) reverse primer for a 
total of 20 µL. Primer sequences used for amplification of STAT3 and Osx-cre 
are as follows: Stat3 forward 5‘-ATT GGA ACC TGG GAC CAA GTG G-3‘, Stat3 
reverse 5‘-ACATGT ACT TAC AGG GTG TGT GC-3‘, Osx-cre forward 5‘- CTC 
TTC ATG AGG AGG ACC CT -3‘, Osx-cre reverse 5‘- GCC AGG CAG GTG CCT 
GGA CAT -3‘. The PCR tubes were then ran in a PTC-11 Peltier Thermal Cycler 
for 39 cylces (1 min at 94°C, 30 sec at 94°C, 30 sec at 55°C, and 30 sec at 68°C). 
The PCR tubes were then removed from the thermal cycler and loaded into a 2.5% 
agarose gel with 1x SYBR safe DNA stain (Life Technologies Corporation, 
Carlsbad, CA, USA). The samples were run alongside a 100 bp ladder. After gel 
electrophoresis, the gel was imaged using a Typhoon FLA 9500 scanner.  
The presence of a 615 bp DNA band (Cre-recombinase) indicated that the mice 
were carrying the Cre transgene (Figure 8). Because Cre is not an endogenous 
gene normally expressed in mammalian species, the absence of this band meant 
that the mouse was not carrying the Cre transgene. The primers for STAT3 
amplification were designed to flank the loxP site upstream and downstream the 
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STAT3 gene sequence, therefore allowing differentiation of STAT3 WT and cKO. 
PCR amplified a 520 bp DNA band for STAT3flox/flox mice and a 480 bp DNA band 
for STAT3+/+ mice (Figure 8). Both the 520 and 480 bp DNA bands were 
amplified for STAT3flox/+ mice but these mice were only used for colony 
maintenance and not experimentation. The expression of Cre was limited to pre-
osteoblast cells and therefore STAT3 was conditionally knocked-out.  
 
2.2.4  Animal Sacrifice 
 
One week prior to sacrificing, the experimental mice were injected 
intraperitoneally with calcein (green fluorochrome label, 30 mg/kg body weight, 
Sigma-Aldrich) and then with alizarin (red fluorochrome label, 50 mg/kg body 
weight, Sigma-Aldrich) two days before sacrifice. Calcein and alizarin label 
incorporate into actively mineralizing bone but have a short half-life in vivo, 
making them an ideal system to label newly formed bone. Once they reached 
eight weeks of age, the experimental mice were first weighed and then were 
euthanized with CO2 inhalation followed by cervical dislocation as a secondary 
means of euthanasia. The left femurs were extracted, stripped of soft tissue, 
wrapped in 0.85% saline-soaked gauze and stored at -20°C. The right femurs 
were extracted, stripped of soft tissue, and immersed in 10% neutral buffered 
formalin for fixation overnight. A piece of tail was also removed to run a 
confirmatory PCR genotype.  
32 
2.2.5  Bone Mineral Density (PIXImus) 
 
Bone mineral density (BMD, g/cm2) and bone mineral content (BMC, g) were 
determined for the left femurs of the experimental mice. BMD and BMC were 
measured and calculated by using peripheral dual-energy X-ray 
absorptionmentry (pDXA, PIXImus II, GE-Lunar Co.).  
 
2.2.6  Micro-Computed Tomography (Micro-CT) Analysis 
 
The left femurs of the 8-week old STAT3 WT and cKO mice were slowly brought 
to room temperature from -20°C and then wrapped in parafilm to keep them from 
drying out during the scanning process. The femurs were positioned and 
stabilized in Styrofoam and mounted on the micro-CT platform for scanning 
(SkyScan 1172, Bruker-microCT, Kontich, Belgium). Scanning parameters were 
set as follows: voltage: 60kV, resolution: 12 μm, binning mode: 2K, filter: Al 0.5 
mm, rotation step: 0.7°, and averaging frame: 2. The femur specimens were 
rotationally scanned for 180° to generate raw projection images per rotation step 
(0.7°). Once scanned, the raw images were reconstructed using the SkyScan 
NRecon software (Bruker-microCT, Kontich, Belgium) using the following 
parameters: Post alignment: variable, Smoothing: 2, Ring artifact reduction: 5, 
Beam hardening: 20, Threshold: 0-0.11 (could differ by study) and File format: 
BMP. The reconstruction process rendered the images into their three-
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dimensional structure allowing for further quantitative analysis using SkyScan 
CT-Analyser (CTAn) (Bruker-microCT, Kontich, Belgium) software analysis. 
Trabecular analysis was performed on a 0.5 and 1.0 mm thick section 1.0 mm 
proximal to the distal growth plate. Bone Volume/Tissue Volume (BV/TV), 
Trabecular Bone Thickness (Tb.Th), Trabecular Bone Number (Tb.N), and 
Trabecular Bone Separation (Tb.Sp) were calculated. Cortical analysis in the 
femoral midshaft region was performed on a single slice with the region of 
interest set to exclude all trabecular bone.  
Three dimensional representations of the midshaft cortical, proximal ⅓ cortical, 
and distal trabecular regions were generated by first selecting the region of 
interest in the SkyScan CT-Analyser software and then exporting as ―3D model‖ 
in the binary images view. The file was then opened in the Skyscan CT-vol 
program for 3D manipulation and imaging.  
 
2.2.7  Biomechanical Testing 
 
After micro-CT scanning was complete, the left femurs were subjected to 3-point 
bending (the femurs did not meet the minimum span requirements for 4-point 
bending). The femurs were slowly brought to room temperature from -20°C and 
then immersed in phosphate buffered saline (pH 7.4) inside petri dishes to keep 
them from drying out until the test was completed. The shortest femur (11.25 mm) 
was used to set the limiting bone span between the bottom two points of the 
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loading apparatus. The span was set at 7.02 mm with the top point set at the 
center, 3.51 mm. The femurs were loaded anterior side upward onto a Bose 
ElectroForce 3200 Test Instrument, pre-loaded to a force of 0.2-0.5 N, pre-
conditioned for 8 cycles (2 Hz), and then monotonically tested to failure at a rate 
of 0.025 mm/s up to 30 N or failure. During each bending test, the load and 
deformation were recorded every 0.04 seconds. From these recordings, 
structural strength (yield force and ultimate force), stiffness (the slope of the 
linear portion of the force vs. displacement curve), and deformation (yield 
deformation, failure deformation and post-yield deformation) were derived at the 
whole bone level (66,67). The point of fracture initiation was noted and measured 
on the anterior face from the proximal end of the femur.  
To derive structural-level mechanical properties, the micro-CT data from the 
same femurs was used to normalize the geometry of the bones. The 3D 
reconstructions of the left femurs were opened in Data Viewer and reoriented 
with the anterior side to the right and the midshaft straightened so that the 
mediolateral axis coincided with the x-axis. 7 slices from the failure site (3 slices 
proximally, 1 slice at failure site, and 3 slices distally) were imported and 
analyzed using SkyScan Software CTAn. The images were saved in binary 
format with a threshold of 70-255 and analyzed using a MATLAB script written by 
Professor Joseph Wallace at Indiana University-Purdue University Indianapolis, 
Department of Biomedical Engineering (BME) and edited by BME graduate 
student Michael Ryne Horn and BME undergraduate student Alycia Berman. 
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Through the MATLAB script, a failure point was defined and an initial point was 
selected to avoid the ‗toe-in‘ region. The script also required a selection of the 
linear portion of the curve with a 0.2% strain offset. The MATLAB script 
correlates the force-displacement curve with the micro-CT data at the failure site 
in order to derive material properties of the femur by transforming it into a stress-
strain curve.  Bone material properties were calculated such as: ultimate stress 
(the highest force per area of a material can hold before failure), ultimate strain 
(maximum deformation representing the bending displacement relative to two 
bottom point span), Young‘s modulus (the slope of the linear region of the stress-
strain curve), and total toughness (the area under the stress-strain curve). 
 
2.2.8  Histology 
 
After being immersed in 10% neutral-buffered formalin overnight, the right femurs 
of the 8-week old WT and cKO mice were cut into a distal and midshaft portion 
and stored in 70% ethanol until processing. Once ready, the femurs were 
dehydrated through a graded series of ethanols before being cleared in xylene, 
2-8 hours per step, under vacuum. The femurs were then infiltrated with a 1:1 
solution of methyl methacrylate (MMA) and 100% ethanol for 2-8 hours and then 
undiluted MMA for another 2-8 hours. Next, the femurs were infiltrated with 
unpolymerized MMA with 4% dibutyl phthalate, a softening agent, for up to one 
week under vacuum. The vacuum was necessary to completely remove trapped 
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air bubbles from the bone samples. Once fully infiltrated, the distal femurs were 
embedded in a mixture of MMA, 4% dibutyl phthalate, and 0.25% Perkadox 16, a 
catalyst, and allowed to sit under vacuum for at least 2 hours before capping the 
vial. The vials were then left to refrigerate overnight and then polymerized at 
room temperature until completely solid. The midshaft portions of the femurs 
were infiltrated and embedded in a similar manner but were placed in a glass 
tube to polymerize. The polymerized blocks containing the distal femurs were 
removed of excess plastic using a band saw and further shaped using a dental 
model trimmer. Thin sections (4 μm) of primarily cancellous bone were cut using 
a rotary microtome outfitted with a tungsten-carbide knife.  A total of five sections 
from each mouse were obtained: two unstained slides for fluorescent label 
scoring, one TRAP slide for osteoclast scoring, one VKM slide for osteoblast 
scoring, and one unstained slide to serve as a spare. Upon polymeriziation of the 
midshaft portions of the femurs, the glass tubes were broken and removed. Thick 
sections (75-100 μm) in the midshaft region were cut using a diamond wire saw 
(Histo-saw, Delaware Diamond Knives, Wilmington, DE) and, when necessary, 
ground to their final thickness of 50 μm using 600 grit wet/dry silicon carbide 
sandpaper (LECO). Three thick sections from each mouse were collected and 
cover-slipped with Eukitt mounting reagent to be scored for cortical parameters.  
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2.2.9  Dynamic Histomorphometry 
 
Thin sections of trabecular bone at the distal femur of 8-week old WT and cKO 
mice were left plasticized and cover-slipped using Eukitt mounting reagent. The 
fluorescent, calcein and alizarin, labels were then visualized using an Olympus 
BX53 light/fluorescent microscope and Olympus DP72 camera interfaced with 
Osteomeasure™ software version 1.01 (OsteoMetrics Inc, Decatur GA).  An area 
0.4 mm proximal to the growth plate and 0.5 mm medial to the endosteal surface 
of the cortical bone was measured (approximately 0.6 mm2 area in total). All 
measurements were taken at 200x magnification under fluorescent light and 
abbreviations were ascribed according to Parfitt et al. (68).  
Thick sections of cortical bone from the midshaft region were also left unstained 
and scored at 200x magnification. Both the periosteal and endosteal bone 
surfaces were measured. Bone parameters measured included total bone 
perimeter, single labeled perimenter, double labeled perimeter, and inter-labeled 
width. These primary data were used to calculate the following: MS/BS = 
[(dL.Pm+(1/2sL.Pm))/B.Pm × 100 (%)], MAR = Ir.L.Th/5 days (μm/day) and 
BFR/BS = MAR × MS/BS × 365 (μm3/μm2/year). 
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2.2.10  Static Histomorphometry 
 
For static histomorphometry, the thin sections of trabecular bone from the distal 
femurs were deplasticized in acetone and then stained by two different 
procedures: (1) a modification of the Von Kossa/MacNeal‘s (VKM) Tetrachrome 
protocol and (2) a tartrate-acid resistant acid phosphatase (TRAP) stain (60).  
VKM staining allows for discrimination between mature, mineralized bone (black) 
and osteoid (pale blue), helping to reveal osteoblast cell morphology. A TRAP 
stain marks area of osteoclast activity with a red color and counterstains their 
nuclei with toluidine blue (69).  
 
2.2.11  TRAP Staining 
 
For thin sections undergoing TRAP staining, the slides were first deplasticized in 
acetone and rehydrated through a series of ethanols (3 minutes per alcohol 
change). The slides were then pre-incubated in sodium acetate buffer (pH 5.0) 
containing 0.2 M sodium acetate and 50 mM sodium tartrate dibasic dehydrate 
for 20 minutes at room temperature (RT). Slides are then switched to a sodium 
acetate buffer solution containing 0.2M sodium acetate, 50mM sodium tartrate 
dibasic dihydrate, 0.5mg/mL napthol AS-MX phosphate, and 1.1 mg/mL fast red 
TR salt for 1 hour at 37°C. After the hour-long incubation, the thin sections were 
counterstained with toluidine blue. Once complete, the slides were cover-slipped 
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with an aqueous-based mounting media. The TRAP stained slides were 
measured for osteoclast activity under bright field at 200x magnification in an 
area 0.4mm proximal to the distal growth plate. The following primary data were 
collected through the OsteoMeasure system: Tissue Area (T.Ar), Bone Area 
(B.Ar), total perimeter (B.Pm), Osteoclast number (N.Oc), and Osteoclast surface 
(Oc.S). From those primary data, the quantified data were derived: Bone 
Volume/Tissue Volume (BV/TV) = B.Ar/T.Ar (%), Osteoclast surface/Trabecular 
Bone surface (Oc.S.BS) = Oc.S/B.Pm (%), and Osteoclast number/Trabecular 
Bone surface (N.Oc/BS) = N.Oc/B.Pm (#/mm). 
 
2.2.12  VKM Staining 
 
For thin sections receiving VKM staining, sections were deplasticized and 
rehydrated with the same procedure as TRAP staining mentioned earlier. Slides 
were then stained in a 5% silver nitrate solution for 10 minutes in the dark, rinsed 
in distilled water 3 times, and stained in a sodium carbonate-formaldehyde 
solution containing 5% sodium carbonate and 25mL formaldehyde per 100mL of 
staining solution. Slides were then rinsed twice and transferred to Farmer‘s 
diminisher solution with potassium ferricyanide for 30 seconds and then washed 
in running tap water for 20 minutes. After washing, sections were rinsed in 
distilled water for one minute and then stained in a 2% MacNeal‘s tetrachrome 
solution for 20 min. Sections were rinsed 3 times after staining, dehydrated in a 
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graded series of ethanols, and cleared using two changes of xylenes. Sections 
were then cover-slipped using a xylene-based mounting media. The VKM slides 
were measured for osteoblasts under bright field at 200x magnification in an area 
0.4 mm proximal to the distal growth plate.  
 
2.3  Immortalized STAT3 Cell Line 
 
2.3.1  Immortalization 
 
Bone marrow stromal cells (BMSC) were immortalized utilizing mTERT by the 
Bidwell Laboratory (70). After being harvested from the femurs of 6-8-week old 
mice, the BMSCs were seeded at 6,000 cells/mm2 and maintained in α–MEM 
culture medium for 10-14 days before being exposed to the viral supernatant. 
Surviving cells were selected, isolated, and expanded.  
 
2.3.2  CRISPR 
 
Once immortalized, the WT BMSCs were modified using the CRISPR/Cas9 gene 
editing tool (71). An oligonucleotide was designed to target the second exon of the 
Stat3 gene (Figure 9) and annealed to a linearized vector pX30/Bbsl (Addgen). 
pX330 expresses the Cas9 gene and the single guide RNA. The cultured cells 
were then screened using PCR and DNA sequencing to identify and isolate 
STAT3 knock-out cell lines.  
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2.3.3  Western Blot 
 
Western blot was used to verify the successful deletion of Stat3 expression in the 
immortalized STAT3 KO cell lines. The cultures from both the immortalized WT 
and KO cell lines were harvested and total protein was isolated. Protein samples 
were then added to a sample buffer and reducing agent mixture. Protein samples 
were then loaded into a NuPage gel and ran in the electrophoresis apparatus at 
200 V for 35 minutes. The protein was then transferred to a nitrocellulose 
membrane within a Western blot module and ran at 30 V for one hour. The 
membrane was then blotted with a total anti-STAT3 primary antibody (Cell 
Signaling Technologies, #9132) and GAPDH secondary antibody (Sigma, G9545) 
and then the membranes were developed.  
 
2.3.4  Proliferation 
 
Immortalized WT and STAT3 KO BMSCs were seeded at an initial density of 
100,000 cells/well in a 6-well culture dish. Cells were cultured for 72 hours in α-
MEM medium with 10% FBS. Cells were then counted after the 72 hours using a 
hemacytometer.  
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2.3.5  Fluid Shear Stress and RT-qPCR 
 
WT and KO STAT3 BMSCs were seeded on type I collagen-coated slides. One 
day prior to fluid shear stress (FSS), the cells were starved with 0.2% FBS in α-
MEM media. The next day, the glass slides were loaded cell side down into the 
fluid flow apparatus and loaded at 12 dyn/cm2 for 30 minutes. The RNA was then 
collected from both the WT and KO FSS slides as well as WT and KO non-
loaded controls. Non-loaded controls were kept in the same incubator under the 
same conditions as the loaded slides. RNA was isolated using TRIzol Reagent 
Kit and purified using RNeasy Mini Kit according to manufacturer‘s protocols. The 
TRIzol Reagent Kit protocol included steps for homogenization, phase separation, 
RNA precipitation, and RNA washing. RNA concentration was determined using 
NanoDrop. Next, cDNA was synthesized from the RNA using Superscript III mix 
and remaining RNA removed using RNase. The cDNA was then used in a RT-
qPCR protocol using SYBR Green PCR Master Mix (Applied Biosystems, Cat. 
NO: 4367659) using primers for both Wnt3a and Wnt5a (Wnt3a Forward: 
CTCCTCTGCAGCCTGAAGC, Wnt3a Reverse: GTGGACGGTGGTGCAGTT; 
Wnt5a Forward: GTGGTCGCTAGGTATGAATAA, Wnt5a Reverse: 
CGCGTATGTGAAGGCCGTC).  
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2.3.6  Alkaline Phosphatase Staining 
 
A modified version of the Sigma Alkaline Phosphatase Staining protocol was 
utilized to stain the immortalized WT and KO BMSCs. BMSCs were cultured in 
osteogenic media containing ascorbic acid and dexamethasone. Upon nearing 
confluency, the cells were fixed using 4% PBF and then incubated in an alkaline 
dye mixture containing Fast Blue RR Salt and Napthol AS-MX Phosphate 
Alkaline solution for 30 minutes in the dark. Lastly, the cells were incubated in 
Mayer‘s Hematoxylin solution to counterstain and then evaluated microscopically 
for regions of alkaline phosphatase staining. 
 
2.4  Bioinformatic Profiling 
 
First, the peak files (Narrow Peak file format) were downloaded from the 
ENCODE database from each cell line used. Narrow Peak file format is a format 
defined by the UCSC ENCODE project and includes the peak loci and 
chromosome number. PeakAnnotator software was then used to upload the 
associated BED files and the reference genome, in our case human genome 19, 
the most recent assembly. BED files contain the coordinates of the peaks 
contained within the original Narrow Peak files. By utilizing PeakAnnotator 
software, the peak files were annotated to the closest transcription start site and 
the nearest gene to that particular TSS. Enriched sites are scored based on the 
false discovery rate (FDR), which is equivalent to the proportion of misidentified 
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sites found among those that are found to be significant. Also given is the q value 
of a peak. This q value represents the minimum FDR at which a peak is 
considered significant and can be compared to a p value when testing a single 
hypothesis (54).  
Basic analysis can be performed with the output of gene lists from ChIP-seq 
experiments in the ENCODE database, like how far the peak is from a known 
transcription start site and from exon-intron boundaries. Pathway analysis was 
run using QIAGEN‘s Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity) and additional gene ontology was analyzed using 
DAVID (72). DAVID works by first inputting the list of overlapping genes that 
STAT3 was found binding to into the Functional Annotation tool. Official Gene 
Symbol was selected as the identifier of the input gene list. Homo sapiens was 
then chosen from the species list since all three cell lines were derived from 
human tissues. 
 
2.16  Statistical Analysis 
 
All data are reported as mean ± S.E.M. (standard error of the mean). The 
differences between groups were tested using a 2-sample t-test using the Minitab 
(Minitab Inc. PA) software. Statistical significance was assumed if P < 0.05.  
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CHAPTER 3. RESULTS 
 
3.1  Diaphonization 
 
As a preliminary method to study the role that STAT3 plays in early osteoblast 
cells, we used whole skeletal preparations of alizarin red/alcian blue stained 
STAT3 WT and cKO newborn pups. This type of skeletal prep allows for the 
visualization of differences in bone tissues, such as shortened long bones, 
widened cartilaginous growth plates, delays in mineralization, and ectopic areas 
of mineralization. The results of this portion of the study were inconclusive, as 
there were not any noticeable differences between the ratios of mineralized to 
non-mineralized tissue when comparing the skeletons of the WT and cKO 
newborn pups (Figures 10 & 11).  
 
3.2  8-week Old cKO Mice 
 
3.2.1  Phenotypes of Conditional STAT3 Knockout Mice 
 
Through the breeding scheme described previously, 5 male WT, 3 male cKO, 6 
female WT, and 5 female cKO mice were generated. There were no significant
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 differences between the body weights of the WT and cKO mice at 8-weeks of 
age. The male cKO mice trended towards decreased body weight, however it did 
not reach significance. Body weight values were as follows: male WT 19.98 ± 
1.58 g, male cKO 16.40 ± 2.06 g, female WT 18.22 ± 0.25 g, and female cKO 
20.14 ± 0.66 g (Figure 12).  Male STAT3 cKO mice demonstrated a 12.25% 
significant decrease in femur length (p < 0.05) (Figures 13 & 14). WT male mice 
femurs were 13.80 ± 0.35 mm while the cKO femurs were 12.11 ± 0.59 mm in 
length. The female cKO mice had a 5.18% increase in femur length that did not 
reach significance.   
At 8 weeks of age, the pre-osteoblast specific STAT3 knockout male mice 
demonstrated a significant decrease in bone mineral density while the female 
cKO mice had a slight increase. The WT males (0.052 ± 0.0007 g/cm2) had 
almost 20% more BMD than their male cKO (0.041 ± 0.002 g/cm2) littermates 
(Figure 15). Bone mineral content was also measured using PIXImus. When 
compared as a ratio of bone mineral content to bone area, the male cKO mice 
also showed a 12% decrease (BMC/area: male WT 0.052 ± 0.0007 g, male cKO 
0.046 ± 0.002 g) (Figure 16).  
 
3.2.2  Micro-CT 
 
The male and female cKO mice both showed slightly decreased Bone 
Volume/Tissue Volume (BV/TV) in the distal trabecular region but neither 
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reached significance when analyzing either a 0.5 or 1.0 mm thick section of 
trabecular bone. The other trabecular parameters in the distal femur region 
(trabecular thickness, number, and separation) were also not significantly 
different.  
Cortical bone analysis in the midshaft region revealed male STAT3 cKO mice to 
have significantly reduced BV/TV, but showed little to no differences in other 
parameters such as mean polar moment, tissue volume, and bone volume. 
Interesting differences, however, arose when the cortical bone in the proximal ⅓ 
of the femur was analyzed. Male cKO mice had a 48% decrease in bone volume 
(Figure 17) (male WT 0.013 ± 0.0009 mm3, male cKO 0.006 ± 0.0006 mm3) but 
showed a 2% increase BV/TV (male WT 96.28 ± 0.64 %, male cKO 98.56 ± 
0.41 %) (Figure 18).  
These differences in structure can be visualized in the 3 dimensional models of 
all four genotypes in Figure 19. As shown, the male STAT3 cKO mice present 
with a severe phenotype with cortical widening in the proximal ⅓ region. 
 
3.2.3  Trabecular Bone Histology 
 
 Histological analysis in the distal trabecular region of the femurs included the 
measurement of fluorochrome labels, TRAP stain, and VKM stain. Examining the 
calcein and alizarin labels showed no significant differences in the bone 
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formation rate between cKO mice and their WT controls (Figure 21). The 
conditional knockout male mice had a 20% decrease in BFR/BS while the female 
conditional knockout mice showed only a 3% decrease in BFR/BS. Though not 
significant, the STAT3 cKO mice of both genders showed decreases in single 
and double labeled perimeter, as well as decreases in interlabel thickness and 
mineral apposition rate (Figure 20).  
Data from the TRAP stained slides from the distal trabecular region showed a 
significant increase in the number of osteoclasts present on the surface of the 
trabecular bone in the male STAT3 cKO mice (Figure 22). The male cKO mice 
(N.Oc. 27 ± 2) had 40% more osteoclasts than the male WT mice (N.OC. 16 ± 
2.01). The female STAT3 cKO mice showed no differences from their WT 
counterparts. The male STAT3 cKO mice had a 60% increase in the amount of 
osteoclast surface/bone surface (Oc.S/BS: male WT 6.70 ± 1.057 mm, male cKO 
17.612 ± 3.68 mm). Calculations of the amount of osteoclast number/tissue area 
(N.Oc./T.Ar) and the amount of osteoclast number/bone perimeter (N.Oc./B.Pm) 
showed similar results, with the male STAT3 cKO mice exhibiting a 40% increase 
in N.Oc./T.Ar and a 50% increase in N.Oc./B.Pm. Male and female STAT3 cKO 
mice both showed a decrease in the number of osteoclasts/osteoclast perimeter; 
however, these differences did not reach a significant level.  
Data gathered from the VKM stained slides from the distal trabecular region 
showed a significant difference in osteoid volume/bone volume (OV/BV) and 
osteoid surface/bone surface (OS/BS) (Figure 23).  
49 
Male STAT3 cKO mice had increased amounts of OV/BV and OS/BS while the 
other bone parameters showed no significant difference.  
 
3.2.4  Cortical Bone Histology 
 
Cortical bone size and growth rate was analyzed in the femoral mishafts of the 8-
week old STAT3 WT and cKO mice by examining cross-sectional slices for their 
fluorochrome labels. Differences arose between the STAT3 WT and cKO in 
cortical bone volume/tissue volume (Ct.BV/TV) and periosteal double-labeled 
perimeter (Ps.dL.Pm). Male STAT3 cKO mice had a 10% decrease in Ct.BV/TV 
(male WT 46.95 ± 0.339%, male cKO 41.961 ± 1.596%) and a 121% increase in 
Ps.dL.Pm (male WT 0.197 ± 0.0235 mm, male cKO 0.437 ± 0.138 mm) (Figure 
24). All the other cortical bone parameters, including single label perimeter on 
both periosteal and endocortical surfaces, showed no significant differences 
between the WT and cKO mice of both genders.  
 
3.2.5  Mechanical Testing: 3 Point Bending 
 
The left femurs from 8-week old pre-osteoblast-specific STAT3 WT and cKO 
mice were subjected to 3 point bending to determine their strength. The femurs 
of the male cKO mice appeared to be weaker and less resistant to fracturing. 
Male cKO showed a 54% decrease in ultimate force (ultimate force: male WT 
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13.66 ± 1.90 N, male cKO 6.22 ± 0.99 N), a 57% decrease in stiffness (stiffness: 
male WT 78.84 ± 9.30 N/mm, male cKO 33.45 ± 7.72 N/mm), a 52% decrease in 
work to yield (work to yield: male WT 0.594 ± 0.0619 mJ, male cKO 0.284 ± 
0.0499 mJ), a 58% decrease in yield stress (yield stress: male WT 110.36 ± 9.90 
MPa, male cKO 46.11 ± 7.72 MPa), a 56% decrease in ultimate stress (ultimate 
stress: male WT 169.40 ± 7.24 MPa, male cKO 74.47 ± 9.29 MPa), and a 71% 
decrease in Young‘s modulus (modulus: male WT 6.80 ± 0.523 GPa, male cKO 
1.97 ± 0.227 GPa) (Figure 25) . The same parameters for the female WT and 
cKO mice showed no significant differences. The male cKO mice experienced a 
99% increase in total displacement, though the standard deviation was too great 
for this value to be significant. Male cKO mice had a slight decrease in toughness 
as compared to male WT mice, but this difference also did not reach a significant 
level.  
 
3.3  Immortalized STAT3 Cell Line 
 
BMSCs were immortalized using mTERT and then modified using CRISPR/Cas9 
editing to ablate the Stat3 gene. Successful deletion of the Stat3 expression was 
confirmed using Western Blot analysis and GAPDH as a control (Figure 9). A 
doubling time experiment was performed on the immortalized WT and KO STAT3 
cell lines to analyze their proliferation capabilities. The STAT3 KO cells 
presented with significantly reduced proliferation rates as compared to the WT 
control cells (Figure 26). The STAT3 KO cells also showed diminished alkaline 
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phosphatase staining in osteogenic culture media, suggesting a reduced 
differentiation potential (Figure 27). The immortalized WT and STAT3 KO cells 
were also subjected to FSS and RT-qPCR analysis of the isolated RNA showed 
significantly lower levels of both Wnt3a and Wnt5a mRNA (Figure 28). 
 
 
3.4  Bioinformatic Profiling 
 
Initial browsing of the ‗ENCODE ChIP-seq Experiment Matrix‘ revealed that three 
different cell lines had been examined for STAT3 binding patterns: GM12878, 
HeLa-S3, and MCF10 cells. All three cell lines are derived from human tissue 
and no STAT3 ChIP-seq experimental data has been deposited for mouse cell 
lines. The GM12878 cell line is derived from B-lymphocytes and represents the 
mesodermal lineage. The HeLa-S3 cell line is from cervical carcinoma cells and 
represents the ectodermal lineage. Lastly, the MCF10+ cells are derived from 
non-tumorigenic, epithelial mammary gland tissue, also representing the 
ectodermal lineage. After generating the peaks from the database the following 
amounts of peaks were found for STAT3: GM12878 - 6487 peaks, HeLa-S3 -
13,834 peaks, and MCF10+ - 39,908 peaks generated. Of these peaks, 1,709 of 
them were overlapping peaks from all three cell lines (Figure 29) and these 
represent the potential target genes for STAT3. The peaks were then narrowed 
down on the basis of their distance from the nearest transcriptional start site 
(TSS), within 5,000 base pairs upstream and 2,000 base pairs downstream from 
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the TSS. This honed the list down to 115 peaks. Further pathway analysis of the 
peaks and their associated gene loci functions best with a reasonable number of 
genes (100-2,000 genes)(72), so we decided to exclusively use all the peaks that 
were generated instead of the ones within our defined TSS range.  
The 1,709 genes were inputted into Ingenuity Pathway Analysis (IPA) software to 
learn more about the relationship between them and potential signaling pathway 
involvement. IPA is able to produce an array of useful data, such as significant 
networks, top functions, and top canonical pathways. The top canonical 
pathways potentially regulated by STAT3 were B-cell receptor signaling (40/171), 
molecular mechanisms of cancer (62/359), ILK signaling (38/181), integrin 
signaling (39/195), and NRF2-mediated oxidative stress response (35/177) 
(Table 1). Shown parenthetically is the ratio of STAT3 bound gene loci to genes 
known to be involved in these top canonical pathways. The top upstream 
regulators were TP53, NR3CI, PDGF BB, TNF, and NFκB. Recurring gene 
ontology amongst the list and their number of associated molecules included 
gene expression (308), cell death and survival (389), cellular development (335), 
and cellular growth and proliferation (406).   
DAVID also uses the KEGG (Kyto Encyclopedia of Genes and Genomes) 
database. This database is useful for mapping target gene lists to known 
signaling pathways (72).  KEGG analysis within the DAVID database identified the 
top five most significant putative pathways regulated by STAT3 as pathways in 
cancer, chronic myeloid leukemia, pancreatic cancer, Jak-STAT signaling, and 
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adherens junction (Table 2). The Wnt signaling pathway was also listed as being 
potentially regulated by STAT3 (Figure 31). 
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CHAPTER 4. DISCUSSION 
 
4.1  Differences in Bone Phenotype 
 
Overall, the male STAT3 cKO mice had significantly shortened femur lengths at 8 
weeks of age, as compared to the WT controls. The males also had decreased 
body weights. At the microscopic level, the cKO males had significantly less BMD 
and BMC/area. The histological analysis also showed that the cKO males 
showed a significant increase in the number of osteoclasts in the distal femur 
region. Also, these same mice had less BV/TV in the midshaft cortical region of 
their femurs. Differences continued to arise between the WT and cKO mice, 
especially in the male mice, after 3-point bending was performed. The femurs of 
the male cKO mice were weaker and less resistant to fracturing. Overall, it 
appears that the female cKO mice were affected very little, if at all, by the loss of 
STAT3 in pre-osteoblast cells. Although no obvious differences were observed 
between WT and cKO mice right after birth, a severe phenotype in the male cKO 
mice was present by 8-weeks of age. The increased number of osteoclasts on 
the bone surface coupled with decreased osteoblast activity (BV/TV) suggests 
some interplay between the two cell types. Cell-to-cell connections between 
osteoblast cells and the progenitors of osteoclast cells are required in order for
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 osteoclast progenitor cells to commit towards osteoclast development (73,74). Also, 
the two genes required for osteoclast formation, M-Csf and RANKL, are 
expressed in osteoblasts. The deficiency of STAT3 in our Osx-cre floxed mice 
might impair differentiation and proliferation of the osteoblasts that jeopardizes 
the normal functioning of osteoblasts. As discussed earlier, osteoblasts also 
possess the ability to inhibit osteoclast formation through the actions of 
osteoprotegerin. It might be possible that the reduction in osteoblast activity is 
linked to the increase in osteoclast via OPG activity.  
A very similar phenotype to our male STAT3 cKO was observed by Zhou and 
colleagues when they conditionally deleted Osterix at several time points post-
natally. They observed large areas of unresorbed calcified cartilage in the area 
near the growth plate of endochondral bones. This area was intensely 
mineralized yet had little to no trabeculae with scant osteoid below this zone of 
hypomineralization. They ascribed this phenotype to the continuous activity of the 
proliferating chondrocytes at the growth plate causing the accumulation of 
calcified cartilage (75).   
The fact that only male mice lacking STAT3 expression in pre-osteoblast cells 
had reduced biomechanical properties and a smaller structure suggests a 
gender-based effect of STAT3 on the quality of the bone matrix. 
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4.2  In Vitro vs. In Vivo Differences 
 
Although no significant differences were observed between the WT and cKO 
newborn pups in terms of mineralization, the in vitro studies using immortalized 
STAT3 WT and KO cell lines showed significant differences. The KO cells had 
decreased proliferation rates and reduced ability to differentiate down the 
osteogenic lineage, as assessed through alkaline phosphatase staining. It is 
possible that there are other genes and protein products that can compensate for 
the loss of STAT3 expression in vivo. Also, the local paracrine action of 
neighboring cells could be involved in the compensation effect. Further studies 
using RT-qPCR could screen for potential genes that act as compensators for 
STAT3 expression in maintaining the normal bone phenotype. 
 
4.3  STAT3‘s Genome Binding Profile 
 
There have been several studies that suggest that Wnt signaling heavily 
influences osteoblast differentiation and function. The reinforcement or depletion 
of β-catenin signaling in osteoblasts specifically causes the decrease or increase 
or osteoclast-mediated bone resorption, respectively. Our ChIP-seq analysis 
suggests that STAT3 might play a role in the Wnt-mediated regulation of bone 
homeostasis (Figure 31).  
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DAVID analysis listed Nrf2-signaling pathway as being potentially regulated by 
STAT3 (Figure 30). Nrf2-signaling is also intriguing to our lab in particular 
because we have ongoing studies looking into the cytoprotective nature of Nrf2, 
especially in bone, using Nrf2 KO mice. Preliminary data have shown that mice 
lacking Nrf2 expression globally have significantly lower BMD, BFR, and ultimate 
force when compared to age-matched littermate wild-type controls (76). The loss 
of STAT3 could have confounding effects, particularly in bone, if STAT3 
activation targets mediators of the Nrf2-signaling pathway.   
 
4.4  Future Directions 
 
The Osx-cre STAT3 floxed study needs to be repeated with larger sample 
numbers in order to determine whether the observed phenotype in this study is 
repeatable or even significant. To aide in the production of more experimental 
mice, an alternative promoter to Osterix could be used to drive the Cre 
recombinase. Osterix is expressed most robustly during early osteoblast 
differentiation, meaning the phenotype might not be replicable with a different 
promoter. If the phenotype is replicable, then further treatment studies could be 
performed in order to rescue the normal phenotype. It would also be intriguing to 
perform the same breeding scheme on ovarectomized female mice to see what 
their bones do without the protective effects of estrogen. In addition to studying 
the femurs of the experimental mice, other long bones, such as the ulna and tibia, 
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should be analyzed to see if the same bone deficiencies manifest in the same 
manner as in the femurs. Although it is unlikely that the deficiencies are unique to 
the femurs, it is interesting that the overall body weight of the cKO mice did not 
significantly decrease. Once again, the lack of significance could solely be 
contributed to low sample numbers within the study, however, it will be 
interesting to look into further. It would also be useful to take a sequence of x-ray 
images and/or PIXImus scans of the mice at different time points during 
development to see when the most marked differences occur.  
Ideally, the next step would be to run a ChIP-seq experiment for STAT3 using 
cells from the osteogenic lineage in order to see binding sites from STAT3 
directly in bone cells to obtain a clearer picture of STAT3‘s place in the 
homeostatic regulatory network of bone. The next step to undertake, with the 
current data that is available, is an RNA sequencing experiment. RNA-seq would 
allow a look at the sequence of the transcriptome of bone cells lacking STAT3 
expression to see if there truly exists a difference in the expression levels of 
STAT3 target genes when STAT3 is removed. 
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Table 1. IPA Top Canonical Pathways 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name p-value Ratio 
B Cell Receptor 
Signaling 
3.19E-10 40/171 (0.234) 
Molecular Mechanisms 
of Cancer 
3.65E-09 62/359 (0.173) 
ILK Signaling 2.13E-08 38/181 (0.21) 
Integrin Signaling 5.61E-08 39/195 (0.2) 
NRF2-mediated 
Oxidative Stress 
Response 
3.53E-07 35/177 (0.198) 
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Table 2. DAVID/KEGG Top Canonical Pathways 
 
Pathway % Genes p-value 
Pathways in cancer 3.9 2.0E-7 
Chronic myeloid 
leukemia 
1.4 2.2E-6 
Pancreatic cancer 1.2 6.2E-5 
Jak-STAT signaling 
pathway 
2.0 1.5E-4 
Adherens junction 1.2 1.6E-4 
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Figure 1: Common membrane receptors for IL-6 family of cytokines. 
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Figure 2: The JAK-STAT signaling pathway. (Figure is adapted from Yu H, 
Kortylewaski M, Pardoll D. Crosstalk between cancer and immune cells: role of 
STAT3 in the tumor microenvironment. (Nature Reviews Immunology. 2007; 
7:41-51.) 
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Figure 3: Three-dimensional structure of activated STAT3 protein dimer. (Figure 
is adapted from O‘Shea JJ, Kanno Y, Chen Y, Levy DE. (Cell Signaling. Stat 
acetylation--a key facet of cytokine signaling? Science. 2005;307:217-218.) 
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Figure 4: The observed bone phenotypes in HIES patients. A: X-ray image of 
spinal scoliosis; B: pathological fracture in distal femur of HIES patient in the 
process of healing; C: Bowing of the legs of a 3-year-old HIES patient 
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Figure 5: Visual determination of the sex of newborn pups based on the 
presence or absence of scrotal pigmentation; female (left) and males (right).  
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Figure 6: Genotyping of the sex genes for diaphonized pups. Females amplify 
one band while males amplify two bands.  
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Figure 7: Breeding scheme for pre-osteoblast specific STAT3 mice. 
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Figure 8: PCR amplification and identification of Cre and STAT3 genes. The 
smaller 490bp belongs to the STAT3 (+/+) (wild type) mice while the 520bp 
fragments contain loxp sites and belongs to the cKO mice. The 615 bp band 
represents the presence Cre. 
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Figure 9: Generation and confirmation of STAT3 KO cell line. a. DNA sequencing 
of the WT and STAT3 KO immortalized cell lines shows that one KO allele has 
an extra base pair while the other KO allele has four missing alleles. b. Western 
blot analysis confirmed the successful deletion of Stat3 expression from the KO 
cells 
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Figure 10: Whole skeletal preparations of newborn WT and cKO pups showed no 
significant differences in body size or mineralization.  
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Figure 11: Diaphonization of the newborn mice. Osx-cre STAT3 WT and cKO 
mice showed no significant differences in the area of mineralization and cartilage 
formation. 
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Figure 12: Body weights of experimental mice at 8 weeks of age. No significant 
differences were observed. 
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Figure 13: Femur lengths of 8 week old experimental mice. Male cKO mice had 
significantly shorter femurs than the WT controls.  
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Figure 14: Dissected femurs of male experimental mice. Conditional STAT3 
males presented with significantly shorter femurs and had widened out cortical 
bone distal to the growth plate.  
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Figure 15: BMD of experimental mice. PIXImus scans of the femurs reveal 
differences in the BMD. Male cKO mice had significantly reduced BMD as 
compared to the WT controls.  
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Figure 16: BMC of experimental mice. PIXImus scans of the femurs reveal 
differences in the BMC/B.Area. Male cKO mice had significantly reduced 
BMC/B.Area as compared to the WT controls.  
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Figure 17: BV cortical bone analysis in the proximal third of the femur near the 
widened portion. Male cKO mice had significantly reduced bone volume in this 
region.  
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Figure 18: BV/TV cortical bone analysis in the proximal third of the femur near 
the widened portion. Male cKO mice had significantly more BV/TV in this region. 
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Figure 19: Three dimensional models comparing the proximal femurs of the 
experimental mice. Male cKO mice presented with severe widening and thinning 
of the cortical bone in this region.  
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Figure 20: Analysis of the fluorochrome labels in the distal trabecular region 
revealed no significant differences.  
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Figure 21: Distal femur fluorochrome labeling. No significant differences were 
observed  
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Figure 22: A. Analysis of TRAP stained sections in the distal trabecular region of 
the femurs showed that the male KO had significantly greater number of 
osteoclasts on the bone surfaces. B. 200x magnification showing the increased 
number of osteoclasts on surface of the KO mice (right).  
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Figure 23: A. Analysis of the VKM slides in the distal trabecular region revealed 
that the male cKO mice had more OV/BV and increased OS/BS. 
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Figure 24: A. Analysis of the fluorescent labels in the femoral midshaft region of 
the femurs of the 8-week-old experimental mice revealed differences in Ct. 
BV/TV and Ps.dL.Pm. Male cKO mice had reduced BV/TV of the cortical bone 
yet increased double labeling on the periosteal surface. B. 200x magnification 
image of the fluorescent labels.  
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Figure 25: Results from biomechanical testing. Mechanical testing utilizing 3 
point bending techniques showed significant differences in multiple parameters, 
including ultimate force, stiffness, work to yield, yield stress, ultimate stress, and 
Young‘s modulus.  
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Figure 26: Doubling time experiment with STAT3 WT and KO cells. KO cell 
showed significantly greater doubling time as compared to the WT control cells.  
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Figure 27: ALP staining of STAT3 WT and KO cells. STAT3 KO cells showed 
less ALP staining as compared to the WT control cells.  
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Figure 28: RT-qPCR analysis of STAT3 WT and KO cell lines. KO cells had 
significantly less mRNA levels of both Wnt3a and Wnt5a. 
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Figure 29: Venn diagram showing the overlap of STAT3 binding sites from the 
three different cell lines found in the ENCODE database. 
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Figure 30: IPA schematic depicting Nrf2-signaling pathway. Bioinformatic 
profiling using Ingenuity Pathway Analysis showed that STAT3 was bound to a 
significant number of genes involved in Nrf2-signaling. 
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Figure 31: DAVID/KEGG schematic depicting Wnt-signaling pathway. 
Bioinformatic profiling using DAVID/KEGG showed that STAT3 was bound to a 
significant number of genes involved in the Wnt signaling pathway (shown by red 
stars). . 
 
